BeOne Medicines Ltd. 8-K

What Happened
BeOne Medicines Ltd. (ticker: ONC) filed a Form 8-K on May 6, 2026 (Item 2.02) to announce its financial results for the three months ended March 31, 2026. The company attached a press release titled “BeOne Medicines Announces First Quarter 2026 Financial Results and Business Updates” as Exhibit 99.1 to the filing.

Key Details

• Filing date: May 6, 2026; reporting period: quarter ended March 31, 2026.
• Item reported: 2.02 — Results of Operations and Financial Condition (press release attached as Exhibit 99.1).
• Exhibit listing also includes Exhibit 104 (cover page formatted in Inline XBRL).
• The press release contains the company’s Q1 2026 quarterly results and business updates (details are in the attached Exhibit 99.1).

Why It Matters
This 8-K provides retail investors with the company’s quarterly earnings and business update for Q1 2026 — key information for assessing recent performance, cash needs, R&D progress and near-term milestones. Investors should review the attached press release (Exhibit 99.1) for specific financial metrics (revenue, net income/loss, cash position) and management commentary, since the Form 8-K itself references that press release as the source of detailed results.